InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $185.660 1.45 (0.77%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19,396 PME signs A$25M-7-Year Visage Open Archive Deal with BayCare 1 Dec 2025 8:29AM $266.540 $185.660 fallen by 30.34%
$19,396 Results AGM 2025 24 Nov 2025 12:12PM $262.300 $185.660 fallen by 29.22%
$19,396 Pro Medicus - AGM 2025 - Presentation 24 Nov 2025 10:05AM $256.890 $185.660 fallen by 27.73%
$19,396 PME signs three new contracts - combined minimum value A$29M 24 Nov 2025 8:28AM $251.320 $185.660 fallen by 26.13%
$19,396 PME signs 5-year, A$44M deal Advanced Radiology Management 17 Nov 2025 9:36AM $248.830 $185.660 fallen by 25.39%
$19,396 Update - Notification of buy-back - PME 17 Nov 2025 8:28AM $248.830 $185.660 fallen by 25.39%
$19,396 Update - Notification of buy-back - PME 14 Nov 2025 9:07AM $255.490 $185.660 fallen by 27.33%
$19,396 Update - Notification of buy-back - PME 13 Nov 2025 9:24AM $257.210 $185.660 fallen by 27.82%
$19,396 Update - Notification of buy-back - PME 12 Nov 2025 8:23AM $254.900 $185.660 fallen by 27.16%
$19,396 Update - Notification of buy-back - PME 11 Nov 2025 9:12AM $257.750 $185.660 fallen by 27.97%
$19,396 Update - Notification of buy-back - PME 10 Nov 2025 8:24AM $252.620 $185.660 fallen by 26.51%
$19,396 Update - Notification of buy-back - PME 7 Nov 2025 10:36AM $251.810 $185.660 fallen by 26.27%
$19,396 Notice of Annual General Meeting and Proxy Form 23 Oct 2025 9:50AM $284.390 $185.660 fallen by 34.72%
$19,396 PME signs 5-year, A$10M deal with University Heidelberg 8 Oct 2025 9:19AM $298.200 $185.660 fallen by 37.74%
$19,396 PME not subject to pharmaceutical tariffs 29 Sep 2025 9:07AM $301.770 $185.660 fallen by 38.48%
$19,396 Pro Medicus Ltd - AGM Date 24 Sep 2025 8:53AM $317.900 $185.660 fallen by 41.60%
$19,396 Change of Director's Interest Notice - Dr Sam Hupert 3 Sep 2025 8:22AM $294.670 $185.660 fallen by 36.99%
$19,396 PME Achieves Authority to Operate U.S Dep Veteran Affairs 1 Sep 2025 9:41AM $298.810 $185.660 fallen by 37.87%
$19,396 PME Achieves Authority to Operate U.S Dep Veteran Affairs 1 Sep 2025 9:41AM $298.810 $185.660 fallen by 37.87%
$19,396 Notification of cessation of securities - PME 25 Aug 2025 11:17AM $307.140 $185.660 fallen by 39.55%
$19,396 Application for quotation of securities - PME 25 Aug 2025 11:13AM $307.140 $185.660 fallen by 39.55%
$19,396 PME FY2025 results presentation 14 Aug 2025 9:45AM $297.150 $185.660 fallen by 37.52%
$19,396 PME FY2025 results presentation 14 Aug 2025 9:45AM $297.150 $185.660 fallen by 37.52%
$19,396 CEO Interview FY25 Results 14 Aug 2025 9:37AM $297.150 $185.660 fallen by 37.52%
$19,396 CEO Interview FY25 Results 14 Aug 2025 9:37AM $297.150 $185.660 fallen by 37.52%

51 - 75 of 668 results

Page 3 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.